Skip to content

Association Between Lipoprotein A Levels and Vulnerable Atherosclerotic Plaques.

Oct 2026 · American Journal of the Medical Sciences · 0 citations · 29 references
Medicine

Abstract

Background

Elevated lipoprotein(a) [Lp(a)] is an established cardiovascular risk factor, but its association with imaging-defined vulnerable plaque features remains incompletely characterized.

Methods

We systematically searched PubMed, Scopus, and Embase for observational studies comparing elevated versus lower Lp(a) levels and reporting thin-cap fibroatheroma (TCFA) or lipid-rich plaques. Random-effects meta-analyses were performed, with the primary TCFA analysis restricted to optical coherence tomography (OCT)-based studies. Sensitivity and geography-based subgroup analyses were also conducted.

Results

Seven studies involving 1,008 patients were included. Elevated Lp(a) was associated with greater odds of TCFA in the primary OCT-based analysis (OR 2.90, 95% CI 1.63 to 5.18; I²=51.0%) and with greater odds of lipid-rich plaques (OR 3.03, 95% CI 1.53 to 6.00; I²=76.9%). Including the MDCTA/MRI study in a TCFA sensitivity analysis yielded a similar association. No significant subgroup differences were observed between Asian and Western studies.

Conclusions

Elevated Lp(a) is associated with imaging-defined features of plaque vulnerability, including TCFA and lipid-rich plaques. These findings should be interpreted cautiously given heterogeneity and the limited number of studies.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.